Intracellular application of hairpin ribozyme genes against hepatitis B virus

Gene Therapy

Volumn 4, Issue 7, 1997, Pages 736-743

  Welch, P J ^a   Tritz, R ^a   Yei, S ^a   Barber, J ^a   Yu, M ^a  

^a Immusol Inc   (United States)

Author keywords

Antiviral; Endogenous polymerase assay; Plasmid independent transcription; Ribozyme kinetics; RNA cleavage

Indexed keywords

COMPLEMENTARY DNA; DNA POLYMERASE; HEPATITIS B SURFACE ANTIGEN; RIBOZYME;

ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME ASSAY; GENE THERAPY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; RNA CLEAVAGE; VIRUS PARTICLE; VIRUS REPLICATION;

DNA VIRUSES; HEPATITIS B VIRUS;

EID: 0030743739     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300441     Document Type: Article

References (37)

1. Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis 1991;11: 84-92.
2. Yoffe B, Noonan CA. Hepatitis B virus: new and evolving issues. Digest Dis Sci 1992;37: 1-9.
3. Offensperger W-B et al. In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligonucleotides. EMBO J 1993;12: 1257-1262.
4. Korba BE, Gerin JL. Antisense oligonucleotides are effective inhibitors of hepatitis B virus replication in vitro. Antiviral Res 1995;28: 225-242.
5. Ganem D, Varmus HE The molecular biology of the hepatitis B viruses. Ann Rev Biochem 1987;56: 651-693.
6. Pugh JC, Bassendine MF. Molecular biology of hepadnavirus replication. Br Med Bull 1990;46: 329-353.
7. Yu M, Poeschla E, Wong-Staal F. Progress towards gene therapy for HIV infection. Gene Therapy 1994;1: 13-19.
8. Welch PJ et al. Inhibition of HIV replication by the hairpin ribozymes. In: Eckstein F, Lilley DM (eds). Nucleic Acids and Molecular Biology, Vol 10. Springer-Verlag: Berlin, Heidelberg, 1996, pp 315-328.
9. Anderson P et al. Mutagenesis of the hairpin ribozyme. Nucleic Acids Res 1994;22: 1096-1100.
10. Berzal-Herranz A et al. Essential nucleotide sequences and secondary structure elements of the hairpin ribozyme. EMBO J 1993;12: 2567-2574.
11. Antao VP, Tinoco I. Thermodynamic parameters for loop formation in RNA and DNA hairpin tetraloops. Nucleic Acids Res 1992;20: 819-824.
12. Sargueil B, Pecchia DB, Burke JM. An improved version of the hairpin ribozyme functions as a ribonucleoprotein complex. Biochemistry 1995;34: 7739-7748.
13. Yu M et al. In vitro and in vivo characterization of a second functional hairpin ribozyme against HIV-1. Virology 1995;206: 381-386.
14. von Weizsacker F, Blum HE, Wands JR. Cleavage of hepatitis B virus RNA by three ribozymes transcribed from a single DNA template. Biochem Biophys Res Commun 1992;189: 743-748.
15. Beck J, Nassal M. Efficient hammerhead ribozyme-mediated cleavage of the structured hepatitis B virus encapsidation signal in vitro and in cell extracts, but not in intact cells. Nucleic Acids Res 1995;23. 4954-4962.
16. Ojwang JO et al. Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme. Proc Natl Acad Sci USA 1992;89: 10802-10806.
17. Welch PJ et al. Potential therapeutic application of hairpin ribozymes: in vitro and in vivo studies of gene therapy for hepatitis virus C infection. Gene Therapy 1996;3: 994-1001.
18. Yu M et al. A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1993;90: 6340-6344.
19. Sells MA, Chen M-L, Asc G. Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA 1987;84: 1005-1009.
20. Chang C et al. Production of hepatitis B virus in vitro by transient expression of cloned HBV DNA in a hepatoma cell line. EMBO J 1987;6: 675-680.
21. Sells MA, Zelent AZ, Shvartsman M, Acs G. Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J Virol 1988;62: 2836-2844.
22. Zhou C et al. Expression of hammerhead ribozymes by retroviral vector to inhibit HTV-1 replication: comparison of RNA levels and viral inhibition. Antisense Nucleic Acid Drug Dev 1996, 6: 17-24.
23. Lieber A et al. Elimination of hepatitis C virus RNA in infected human hepatocytes by adenovirus-mediated expression of ribozymes. J Virol 1996;70: 8782-8791.
24. Sakamoto N, Wu C, Wu G. Intracellular cleavage of hepatitis C virus RNA and inhibition of viral protein translation by hammerhead ribozymes. J Clin Invest 1996;12: 2720-2728.
25. De Man RA, Heijtink RA, Niesters HGM, Schalm SW. New developments in antiviral therapy for chronic hepatitis B infection. Scand J Gasteroenterol 1995;30: 100-104.
26. Haria M, Benfleld P. Interferon-alpha-2a: a review of its pharmacological properties and therapeutic use in the management of viral hepatitis. Drugs 1995;50: 873-896.
27. Blum HE et al. Antiviral therapy of hepatitis B virus infection: blocking viral gene expression. Adv Drug Delivery Rev 1995;17: 321-331.
28. Carreno V, Quiroga JA. New and forthcoming therapies for viral hepatitis. J Hepatol 1996;24: 74-76.
29. Schalm SW et al. New nucleoside analogs for chronic hepatitis B. J Hepatol 1995;22: 52-56.
30. Colacino JM. Mechanisms for the anti-Hepatitis B virus activity and mitochondrial toxicity of fialuridine (FIAU). Antiviral Res 1996, 29: 125-139.
31. Yao ZQ et al. Inhibition of hepatitis B virus in vitro by antisense oligonucleotides. Acta Virol 1996;40: 35-39.
32. Korba BE. In vitro evaluation of combination therapies against hepatitis B virus replication. Antiviral Res 1996;29: 49-51.
33. Weiner SM et al. Tissue tropism of adeno-associated virus (human type 2) in mice. J Am Soc Hematol 1996;88 (Suppl. 1): 3906.
34. Ponnazhagan S et al. Adeno-associated virus 2-mediated gene transfer in vivo: organ tropism and expression of transduced sequences in mice. Gene 1997;190: 203-210.
35. Flotte TR et al. An improved system for packaging recombinant adeno-associated virus vector capable of in vivo transduction. Gene Therapy 1995;2: 29-37.
36. Smith TA et al. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice Nat Genet 1993;5: 397-402.
37. Mittereder N et al. Evaluation of efficacy and safety of in vitro adenovirus-mediated gene transfer of the human cystic fibrosis transmembrane conductance regulator cDNA. Hum Gene Ther 1994;5: 225-234.